المؤلفون: Speiser DE; Clinical Tumor Immune-Biology Unit, Ludwig Institute for Cancer Research, Lausanne branch, Switzerland. daniel.speiser@hospvd.ch, Schwarz K, Baumgaertner P, Manolova V, Devevre E, Sterry W, Walden P, Zippelius A, Conzett KB, Senti G, Voelter V, Cerottini JP, Guggisberg D, Willers J, Geldhof C, Romero P, Kündig T, Knuth A, Dummer R, Trefzer U, Bachmann MF

المصدر: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2010 Oct; Vol. 33 (8), pp. 848-58.

نوع المنشور: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Cancer Vaccines* , Vaccines, Virus-Like Particle*, CD8-Positive T-Lymphocytes/*metabolism , Melanoma/*therapy , Skin Neoplasms/*therapy , T-Lymphocyte Subsets/*metabolism, Adult ; Aged ; Animals ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Cell Differentiation ; Cells, Cultured ; Female ; HLA-A2 Antigen/genetics ; HLA-A2 Antigen/metabolism ; Humans ; Immunologic Memory ; Lymphocyte Activation ; MART-1 Antigen/chemistry ; MART-1 Antigen/immunology ; Male ; Melanoma/immunology ; Melanoma/pathology ; Melanoma/physiopathology ; Mice ; Mice, Transgenic ; Middle Aged ; Nanoparticles/chemistry ; Oligodeoxyribonucleotides/chemistry ; Oligodeoxyribonucleotides/immunology ; Peptide Fragments/chemistry ; Peptide Fragments/immunology ; Skin Neoplasms/immunology ; Skin Neoplasms/pathology ; Skin Neoplasms/physiopathology ; T-Lymphocyte Subsets/immunology ; T-Lymphocyte Subsets/pathology ; Treatment Outcome